Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
10 studies found for:    lcp-tacro
Show Display Options
Rank Status Study
1 Completed LCP-Tacro vs. Azathioprine for the Treatment of Autoimmune Hepatitis
Condition: Autoimmune Hepatitis
Interventions: Drug: LCP-Tacro (tacrolimus);   Drug: Azathioprine
2 Completed A Phase 2 Double-Blind, Double-dummy, Multicenter, Prospective, Randomized Study of the Pharmacokinetics of LCP-Tacro Tablets, Once-Daily, Compared to Prograf Capsules, Twice-daily, for the Prevention of Acute Allograft Rejection in De Novo Adult Kidney Transplant Recipients
Condition: Renal Failure
Interventions: Drug: LCP-Tacro tablets;   Drug: Prograf
3 Active, not recruiting Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)
Conditions: Renal Failure;   Tremors
Interventions: Drug: Prograf;   Drug: LCP-Tacro
4 Completed Pharmacokinetics of LCP-Tacro in Stable Kidney Transplant Patients
Conditions: Kidney Transplantation;   Immunosuppressive Therapy
Intervention: Drug: LCP Tacro-2011
5 Completed Pharmacokinetics of LCP-Tacro in Stable Liver Transplant Patients
Conditions: Liver Transplantation;   Immunosuppressive Therapy
Intervention: Drug: LCP Tacro-2012
6 Completed Pharmacokinetics of LCP-Tacro™ Once Daily and Prograf® Twice A Day in Adult De Novo Liver Transplant Patients
Condition: Liver Transplantation
Interventions: Drug: LCP - Tacro™ tablets;   Drug: Prograf®
7 Active, not recruiting Double-Blind,Double-Dummy,Effic/Safety,LCP-Tacro™ Vs Prograf®,Prevention Rejection,De Novo Adult Kidney Tx
Condition: Renal Failure
Interventions: Drug: Prograf (tacrolimus);   Drug: LCP-Tacro
8 Completed Safety and Efficacy of LCP-Tacro™ Once Daily in Stable Renal Transplant Patients Converted From Prograf® Twice Daily
Condition: Acute Allograft Rejection
Interventions: Drug: LCP-Tacro™ Tablets (tacrolimus);   Drug: Prograf® capsules (tacrolimus)
9 Completed Pharmacokinetics of LCP-Tacro(TM) Once Daily And Prograf® Twice A Day in Adult De Novo Kidney Transplant Patients
Conditions: Kidney Transplantation;   Renal Transplantation
Interventions: Drug: tacrolimus (Tacro™);   Drug: Prograf®
10 Recruiting Crossover Study to Compare Pharmacokinetics of Once Daily Extended Release Tacrolimus Tablets to Generic Tacrolimus Capsules Twice Daily
Condition: Stable Renal Transplant Patients
Intervention: Drug: Tacrolimus

Indicates status has not been verified in more than two years